4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole → N-(2-(1H-indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)isobutyramide
Reaction equation
[CH3:23][C:24]1([CH3:25])[C:26]([CH3:27])([CH3:28])[O:29][B:30]([c:31]2[c:32]3[cH:33][n:34][nH:35][c:36]3[cH:37][cH:38][cH:39]2)[O:40]1.[Cl:1][c:2]1[n:3][c:4]([N:17]2[CH2:18][CH2:19][O:20][CH2:21][CH2:22]2)[c:5]2[c:6]([n:7]1)[cH:8][c:9]([NH:11][C:12]([CH:13]([CH3:14])[CH3:15])=[O:16])[s:10]2>>[c:2]1(-[c:31]2[c:32]3[cH:33][n:34][nH:35][c:36]3[cH:37][cH:38][cH:39]2)[n:3][c:4]([N:17]2[CH2:18][CH2:19][O:20][CH2:21][CH2:22]2)[c:5]2[c:6]([n:7]1)[cH:8][c:9]([NH:11][C:12]([CH:13]([CH3:14])[CH3:15])=[O:16])[s:10]2Participants
3
Sources & evidence
- ORD record
- ord-8e6734031def4fc2be81bc986ab90bf5
- Source dataset
- Training data from https://doi.org/10.1039/C8SC04228D (2/10)
Reaction notes
Loading…